ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 751 filers reported holding ASTRAZENECA PLC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $872,570 | -4.0% | 12,885 | +1.4% | 0.17% | -0.6% |
| Q2 2023 | $909,175 | +3.2% | 12,703 | +0.1% | 0.17% | -3.9% |
| Q1 2023 | $880,764 | -0.4% | 12,689 | -2.7% | 0.18% | -6.8% |
| Q4 2022 | $884,156 | +19.0% | 13,041 | -3.8% | 0.19% | +0.5% |
| Q3 2022 | $743,000 | -23.0% | 13,550 | -7.3% | 0.19% | -23.1% |
| Q2 2022 | $965,000 | -0.9% | 14,611 | -0.5% | 0.25% | +9.3% |
| Q1 2022 | $974,000 | +14.5% | 14,687 | +0.5% | 0.23% | +15.9% |
| Q4 2021 | $851,000 | -2.4% | 14,617 | +0.7% | 0.20% | -16.3% |
| Q3 2021 | $872,000 | +56.0% | 14,522 | +55.7% | 0.23% | +55.3% |
| Q2 2021 | $559,000 | +27.9% | 9,324 | +6.1% | 0.15% | +14.5% |
| Q1 2021 | $437,000 | +7.6% | 8,789 | +8.2% | 0.13% | -0.8% |
| Q4 2020 | $406,000 | +20.1% | 8,123 | +20.4% | 0.13% | +3.1% |
| Q3 2020 | $338,000 | -7.9% | 6,744 | -2.9% | 0.13% | -14.1% |
| Q2 2020 | $367,000 | +4.3% | 6,945 | +1.5% | 0.15% | -3.9% |
| Q1 2020 | $352,000 | -2.8% | 6,845 | -5.8% | 0.16% | +16.5% |
| Q4 2019 | $362,000 | – | 7,263 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |